Fragmin Related Clinical Trials
Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis [Active, not recruiting]
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy [Recruiting]
Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients [Completed]
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter [Completed]
Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic or Unresectable Kidney Cancer [Active, not recruiting]
Use Of Fragmin In Hemodialysis [Recruiting]
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients [Completed]
Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma [Active, not recruiting]
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients [Active, not recruiting]
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) [Completed]
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery [Completed]
PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot [Completed]
Thoracic Surgery Extended Low-Molecular Weight Heparin VTE Prophylaxis--Pilot Trial [Not yet recruiting]
The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086) [Completed]
Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT [Terminated]
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma [Completed]
Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss [Completed]
TIPPS: Thrombophilia in Pregnancy Prophylaxis Study [Completed]
Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty) [Completed]
DVT Prophylaxis in Orthopaedic Oncology Patients - A Safety Study [Active, not recruiting]
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients [Terminated]
Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome. [Recruiting]
Management of Superficial Thrombophlebitis [Completed]
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer [Completed]
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer [Terminated]
An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin® [Completed]
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients [Completed]
Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis [Recruiting]
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer [Completed]
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer [Terminated]
Low Molecular Weight Heparin in Recurrent Implantation Failure [Completed]
Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice [Completed]
PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin. [Recruiting]
Thromboprophylaxis in Critically Ill Patients [Terminated]
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients [Terminated]
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome [Terminated]
Anticoagulation Length in Cancer Associated Thrombosis [Not yet recruiting]
Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo [Completed]
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer [Completed]
Low Molecular Weight Heparin for Hemodialysis Anticoagulation [Completed]
Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT) [Completed]
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients [Recruiting]
Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis [Completed]
Treatment of Upper Extremity Deep-Vein Thrombosis [Completed]
Dalteparin in Preventing Blood Clots in Patients With Lung Cancer [Recruiting]
Treatment of Blood Clots in Children With Cancer [Recruiting]
Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis [Recruiting]
Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study) [Completed]
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) [Completed]
A Pilot Feasibility And Safety Multicenter Trial Of Administering Weight FiXET Study [Not yet recruiting]
The Use of Low Molecular Weight Heparin in Hemodiafiltration [Completed]
Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study [Terminated]
Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme [Completed]
Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis [Completed]
Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation [Terminated]
Prophylaxis of Venous Thromboembolism After Bariatric Surgery [Recruiting]
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism [Terminated]
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Completed]
The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis [Completed]
Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer [Completed]
Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis [Recruiting]
Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum [Completed]
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure [Recruiting]
Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients [Not yet recruiting]
Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs [Terminated]
Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery [Completed]
Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome [Completed]
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery [Completed]
LMWH to Prevent Preeclampsia and Fetal Growth Restriction [Terminated]
Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) [Active, not recruiting]
The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial [Completed]
Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) [Completed]
Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery [Completed]
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services [Active, not recruiting]
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [Completed]
The Role of Low Molecular Weight Heparins (LMWH) Combined With Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma [Recruiting]
Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot [Completed]
Comparison of Anti-Xa Activity of ENOXA � Versus LOVENOX � in Acute Coronary Syndrome [Completed]
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients [Completed]
Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke [Recruiting]
Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients [Completed]
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis [Enrolling by invitation]
Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis [Suspended]
Enoxamed Study in the Treatment of Acute Coronary Syndromes [Completed]
Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer [Terminated]
Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure [Recruiting]
Cancer Venous Thromboembolism (VTE) [Recruiting]
Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration [Completed]
Self-management of Low Molecular Weight Heparin Therapy [Completed]
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury [Suspended]
Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) [Completed]
Once Weekly Subcutaneous Ports for the Administration of Anticoagulants [Completed]
The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section [Completed]
Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients [Terminated]
Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies [Active, not recruiting]
Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients [Completed]
Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function [Completed]
|
